Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 170

1.

Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24.

Wang F, Smith N, Maier L, Xia W, Hammerberg C, Chubb H, Chen C, Riblett M, Johnston A, Gudjonsson JE, Helfrich Y, Kang S, Fisher GJ, Voorhees JJ.

Br J Dermatol. 2012 Jul;167(1):92-102. doi: 10.1111/j.1365-2133.2012.10961.x.

PMID:
22458549
[PubMed - indexed for MEDLINE]
2.

Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.

Johnston A, Fritz Y, Dawes SM, Diaconu D, Al-Attar PM, Guzman AM, Chen CS, Fu W, Gudjonsson JE, McCormick TS, Ward NL.

J Immunol. 2013 Mar 1;190(5):2252-62. doi: 10.4049/jimmunol.1201505. Epub 2013 Jan 28.

PMID:
23359500
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.

Lizzul PF, Aphale A, Malaviya R, Sun Y, Masud S, Dombrovskiy V, Gottlieb AB.

J Invest Dermatol. 2005 Jun;124(6):1275-83.

PMID:
15955104
[PubMed - indexed for MEDLINE]
Free Article
4.

TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques.

Gottlieb AB, Chamian F, Masud S, Cardinale I, Abello MV, Lowes MA, Chen F, Magliocco M, Krueger JG.

J Immunol. 2005 Aug 15;175(4):2721-9.

PMID:
16081850
[PubMed - indexed for MEDLINE]
Free Article
5.

Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes.

Zaba LC, Suárez-Fariñas M, Fuentes-Duculan J, Nograles KE, Guttman-Yassky E, Cardinale I, Lowes MA, Krueger JG.

J Allergy Clin Immunol. 2009 Nov;124(5):1022-10.e1-395. doi: 10.1016/j.jaci.2009.08.046.

PMID:
19895991
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Mechanisms of action of etanercept in psoriasis.

Tan JK, Aphale A, Malaviya R, Sun Y, Gottlieb AB.

J Investig Dermatol Symp Proc. 2007 May;12(1):38-45. Review.

PMID:
17502868
[PubMed - indexed for MEDLINE]
Free Article
7.

Etanercept downregulates the Th17 pathway and decreases the IL-17+/IL-10+ cell ratio in patients with psoriasis vulgaris.

Antiga E, Volpi W, Cardilicchia E, Maggi L, Filì L, Manuelli C, Parronchi P, Fabbri P, Caproni M.

J Clin Immunol. 2012 Dec;32(6):1221-32. doi: 10.1007/s10875-012-9716-x. Epub 2012 Jun 15.

PMID:
22699761
[PubMed - indexed for MEDLINE]
8.

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses.

Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Suárez-Fariñas M, Fuentes-Duculan J, Novitskaya I, Khatcherian A, Bluth MJ, Lowes MA, Krueger JG.

J Exp Med. 2007 Dec 24;204(13):3183-94. Epub 2007 Nov 26. Erratum in: J Exp Med. 2008 Aug 4;205(8):1941. Suárez Fariñas, Mayte [corrected to Suárez-Fariñas, Mayte].

PMID:
18039949
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept.

Caldarola G, De Simone C, Carbone A, Tulli A, Amerio P, Feliciani C.

Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4):961-6.

PMID:
20074459
[PubMed - indexed for MEDLINE]
10.

Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues.

Bosè F, Raeli L, Garutti C, Frigerio E, Cozzi A, Crimi M, Caprioli F, Scavelli R, Altomare G, Geginat J, Abrignani S, Reali E.

Clin Immunol. 2011 May;139(2):164-76. doi: 10.1016/j.clim.2011.01.015. Epub 2011 Jan 31.

PMID:
21334981
[PubMed - indexed for MEDLINE]
11.

Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept.

Günther C, Blau K, Förster U, Viehweg A, Wozel G, Schäkel K.

Exp Dermatol. 2013 Aug;22(8):535-40. doi: 10.1111/exd.12190.

PMID:
23879812
[PubMed - indexed for MEDLINE]
12.

Psoriasis and other Th17-mediated skin diseases.

Tokura Y, Mori T, Hino R.

J UOEH. 2010 Dec 1;32(4):317-28. Review.

PMID:
21226422
[PubMed - indexed for MEDLINE]
13.

Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response.

Quaglino P, Bergallo M, Ponti R, Barberio E, Cicchelli S, Buffa E, Comessatti A, Costa C, Terlizzi ME, Astegiano S, Novelli M, Cavallo R, Bernengo MG.

Dermatology. 2011;223(1):57-67. doi: 10.1159/000330330. Epub 2011 Aug 25.

PMID:
21865674
[PubMed - indexed for MEDLINE]
14.

Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy.

Iyer S, Yamauchi P, Lowe NJ.

Br J Dermatol. 2002 Jan;146(1):118-21.

PMID:
11841377
[PubMed - indexed for MEDLINE]
15.

Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients.

Swindell WR, Johnston A, Voorhees JJ, Elder JT, Gudjonsson JE.

BMC Genomics. 2013 Aug 1;14:527. doi: 10.1186/1471-2164-14-527.

PMID:
23915137
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Etanercept for psoriasis: two case reports.

Fidalgo A, Baptista J, Rocha Páris F, Caldas Lopes L, Ferreira A.

Int J Clin Pharmacol Res. 2005;25(4):159-63.

PMID:
16402631
[PubMed - indexed for MEDLINE]
17.

Expression of antimicrobial peptides and proteins in etanercept-treated psoriasis patients.

Gambichler T, Kobus S, Kobus A, Tigges C, Scola N, Altmeyer P, Kreuter A, Bechara FG, Skrygan M.

Regul Pept. 2011 Apr 11;167(2-3):163-6. doi: 10.1016/j.regpep.2011.02.001. Epub 2011 Feb 12.

PMID:
21324346
[PubMed - indexed for MEDLINE]
18.

Granulocyte colony-stimulating-factor-induced psoriasiform dermatitis resembles psoriasis with regard to abnormal cytokine expression and epidermal activation.

Mössner R, Beckmann I, Hallermann C, Neumann C, Reich K.

Exp Dermatol. 2004 Jun;13(6):340-6.

PMID:
15186319
[PubMed - indexed for MEDLINE]
19.

CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept.

Campanati A, Goteri G, Simonetti O, Ganzetti G, Giuliodori K, Stramazzotti D, Morichetti D, Bernardini ML, Mannello B, Fabris G, Offidani A.

Br J Dermatol. 2007 Dec;157(6):1155-60. Epub 2007 Oct 4.

PMID:
17916208
[PubMed - indexed for MEDLINE]
20.

The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept.

Kanelleas A, Liapi C, Katoulis A, Stavropoulos P, Avgerinou G, Georgala S, Economopoulos T, Stavrianeas NG, Katsambas A.

Clin Exp Dermatol. 2011 Dec;36(8):845-50. doi: 10.1111/j.1365-2230.2011.04131.x. Epub 2011 Jul 25.

PMID:
21790728
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk